MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immuneering (IMRX) Earnings Date & Reports
Immuneering Corp is a biopharmaceutical company... Show more
A.I. Advisor
published Earnings
IMRX is expected to report earnings to rise 30.14% to -27 cents per share on August 12
Q2'26
Est.
$-0.27
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.02
The last earnings report on May 15 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 1.38M shares outstanding, the current market capitalization sits at 260.41M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
53
Web
https://www.immuneering.com